Markus Ewert

Founder & Managing Director; Board member & Executive Advisor
Summary
Markus Ewert is a highly accomplished professional with a diverse background in business, healthcare, and pharmaceutical industries.
He holds a Master of Business Administration (MBA) from the University of Chicago and a Doctor of Philosophy (PhD) in Molecular Biology and pharmacology from Heidelberg University.
Currently, Markus Ewert serves as the Chairman of the Board and Executive Advisor at Semalytix, a significant role where he provides strategic guidance and leadership.
With a rich history of leadership positions, Markus Ewert has previously held the title of Chairman of the Board at Retinai, Founder & Managing Director at The Healthcare Advisory, and CEO at ALENTIS Therapeutics.
Markus Ewert's career has seen him in pivotal roles such as Entrepreneur in Residence at BioMedPartners, Chief Business Officer at Ablynx, and Global Head of Business Development and Corporate Development at GE Healthcare.
His expertise extends to strategic planning, business development, and mergers and acquisitions, as evidenced by his tenure as Global Head of Strategy, Business Development & Licensing, and M&A Molecular Diagnostics at Novartis Pharma AG.
Prior to his current roles, Markus Ewert has contributed significantly to various organizations, including Novartis Pharma AG, Xerion, Axxima, Schwarz Pharma, and The Boston Consulting Group.
Markus Ewert's academic qualifications coupled with his extensive professional experience make him a standout figure in the industry, bringing a wealth of knowledge and expertise to every role he undertakes.